Publications by authors named "R Chaisson"

Claim this Profile
A
A 3-month clofazimine-rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial.
John Z Metcalfe, Isabelle R Weir, Kimberly K Scarsi, Alberto Mendoza-Ticona, Samuel Pierre, Richard Chaisson

Lancet Infect Dis· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimising child-friendly TB preventive treatment regimens.
C Mulder, A J Bergman, F Mulatu, R Chaisson, G Churchyard

IJTLD Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment completion and challenges in rolling out 12-dose weekly rifapentine plus isoniazid to prevent tuberculosis among people living with HIV and pediatric household contacts in Brazil.
Isadora Salles, Jamile Garcia de Oliveira, Alexandra Brito de Souza, Silvia Cohn, Renata Spener-Gomes, Richard E Chaisson

J Bras Pneumol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventing multidrug resistant tuberculosis: the dawn of a new era.
Gavin J Churchyard, Susan Swindells, Amita Gupta, N Sarita Shah, Michael Hughes, Richard E Chaisson

Clin Infect Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of a choice architecture-based intervention on prescribing of TB preventive treatment to people living with HIV in southern Africa (the CAT study): a cluster-randomised trial.
Kate Shearer, Bareng A S Nonyane, Christiaan Mulder, Emmanuel Kaonga, Rose Nyirenda, Richard E Chaisson

BMJ Glob Health· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis